Pharmazeutische Zusammensetzung enthaltend einen progestationäle Kortikoid und einen selektiven Östrogenrezeptormodulator

Composition pharmaceutique contenant un corticoide progestatif et un modulateur sélectif du récepteur oestrogénique

Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator

Abstract

The invention relates to the combined use of a progestational corticoid active compound and a selective estrogen receptor modulator to modify the side-effects of corticoid therapy.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (3)

    Publication numberPublication dateAssigneeTitle
    US-5886049-AMarch 23, 1999Nippon Kayaku Kabushiki Kaisha, Orion-Yhtyma OyRemedy for autoimmune diseases
    WO-9322685-A1November 11, 1993The Government Of The United States Of America As Represented By The Department Of Health And Human ServicesMoyens d'evaluation servant a detecter la reactivite inflammatoire
    WO-9402130-A1February 03, 1994Massachusetts Institute Of Technology, Arch Development CorporationControl of wound scar production with calcium antagonists alone or in a combination with a steroid

NO-Patent Citations (4)

    Title
    HERBAI G: "Scleroderma (progressive systemic sclerosis, PSS);pathophysiological, clinical and pharmacological aspects of the syndrome." ACTA MEDICA ACADEMIAE SCIENTIARUM HUNGARICAE. HUNGARY 1978, vol. 35, no. 3-4, 1978, pages 201-211, XP008019057 ISSN: 0001-5989
    RECCHIA F ET AL: "Beta-interferon, retinoids and tamoxifen as maintenance therapy in metastatic breast cancer. A pilot study." LA CLINICA TERAPEUTICA. ITALY OCT 1995, vol. 146, no. 10, October 1995 (1995-10), pages 603-610, XP008019059 ISSN: 0009-9074
    SAVELLI BRENT A ET AL: "Successful treatment of sclerosing cervicitis and fibrosing mediastinitis with tamoxifen." CHEST, vol. 111, no. 4, 1997, pages 1137-1140, XP008019063 ISSN: 0012-3692
    TORMEY D C ET AL: "Short term high density systemic therapy for metastatic breast cancer." BREAST CANCER RESEARCH AND TREATMENT. NETHERLANDS 1985, vol. 5, no. 2, 1985, pages 177-188, XP008019058 ISSN: 0167-6806

Cited By (6)

    Publication numberPublication dateAssigneeTitle
    US-8247456-B2August 21, 2012Repros Therapeutics Inc.Dosing regimes for trans-clomiphene
    US-8372887-B2February 12, 2013Repros Therapeutics Inc.Trans-clomiphene for metabolic syndrome
    US-8377991-B2February 19, 2013Repros Therapeutics Inc.Trans-clomiphene for metabolic syndrome
    US-8618176-B2December 31, 2013Repros Therapeutics Inc.Methods and materials for the treatment of testosterone deficiency in men
    US-9687458-B2June 27, 2017Repros Therapeutics Inc.Trans-clomiphene for use in cancer therapy
    WO-03063859-A1August 07, 2003Nordic Bioscience A/SSuppression de la degradation du cartilage a l'aide du recepteur des oestrogenes